Atlas Trials

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

Clinical trial NCT02446444 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02446444
Sponsor
University of Sydney
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Prostatic Neoplasms
Start date
2014-03-01
Primary completion
2026-06-01
Enrollment
802

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.